British American Tobacco (BTI) is being considered for aggressive buying in 2025 due to its attractive 8% yield, a 6% growth plan, and a potential 36% upside return. The company's dividend is deemed safe, supported by a strong balance sheet, stable cash flow, and a 65% payout ratio policy. BTI's RRP portfolio is expanding rapidly, with expectations of 35% of sales from RRPs by 2030, aiming to double non-smoking customers.